Treatment adherence and QoL with intermittent PTH therapy: Results from a multicentre Italian study after 6 months
- Authors: Minisola, S.; Patella, V.; Sessa, G.; Raso, I.; Bevilacqua, M.; Fabbri, A.; Moretti, B.; Scarpellini, M.; Cangelosi, A.; Letizia Mauro, G.; Frisina, N.; Mancusi, D.
- Publication year: 2011
- Type: Abstract in rivista (Abstract in rivista)
- OA Link: http://hdl.handle.net/10447/253718
Abstract
This ongoing multicentre study was carried out to investigate the adherence to intermittent parathyroid hormone treatment and the effect on QoL in a typical Italian population eligible for drug reimbursement (i.e. a new vertebral or hip fracture following at least one year of anti-resorptive therapy or three severe vertebral fractures or two severe and one femur fracture). 204 female patients (mean age: 72.6±8.3) were enrolled between March 2008 and April 2009. These patients were treated with PTH (PTH 1–34 or PTH 1–84) according to Italian legislation. Here, we report the results obtained at month 6.